197 related articles for article (PubMed ID: 20303485)
1. Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes.
Guastella E; Longo RA; Carmina E
Fertil Steril; 2010 Nov; 94(6):2197-201. PubMed ID: 20303485
[TBL] [Abstract][Full Text] [Related]
2. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
Barber TM; Wass JA; McCarthy MI; Franks S
Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
[TBL] [Abstract][Full Text] [Related]
3. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of plasma ghrelin levels in women with polycystic ovary syndrome, in hyperandrogenic women and in normal controls.
Panidis D; Farmakiotis D; Koliakos G; Rousso D; Kourtis A; Katsikis I; Asteriadis C; Karayannis V; Diamanti-Kandarakis E
Hum Reprod; 2005 Aug; 20(8):2127-32. PubMed ID: 15890737
[TBL] [Abstract][Full Text] [Related]
5. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
[TBL] [Abstract][Full Text] [Related]
6. [Clinical, hormonal and metabolic characteristics of different phenotypes of polycystic ovary syndrome, in Bulgarian population].
Kavardzhikova S; Pechlivanov B
Akush Ginekol (Sofiia); 2010; 49(4):32-7. PubMed ID: 20734639
[TBL] [Abstract][Full Text] [Related]
7. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.
Chae SJ; Kim JJ; Choi YM; Hwang KR; Jee BC; Ku SY; Suh CS; Kim SH; Kim JG; Moon SY
Hum Reprod; 2008 Aug; 23(8):1924-31. PubMed ID: 18579512
[TBL] [Abstract][Full Text] [Related]
8. Polycystic ovary syndrome in bulimic women--an evaluation based on the new diagnostic criteria.
Naessén S; Carlström K; Garoff L; Glant R; Hirschberg AL
Gynecol Endocrinol; 2006 Jul; 22(7):388-94. PubMed ID: 16864149
[TBL] [Abstract][Full Text] [Related]
9. The spectrum of androgen excess disorders.
Carmina E
Fertil Steril; 2006 Jun; 85(6):1582-5. PubMed ID: 16759919
[TBL] [Abstract][Full Text] [Related]
10. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
[TBL] [Abstract][Full Text] [Related]
11. The androgenic profile of women with non-insulin-dependent diabetes mellitus.
Tok EC; Ertunc D; Evruke C; Dilek S
J Reprod Med; 2004 Sep; 49(9):746-52. PubMed ID: 15493567
[TBL] [Abstract][Full Text] [Related]
12. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism.
Ozdemir S; Ozdemir M; Görkemli H; Kiyici A; Bodur S
Acta Obstet Gynecol Scand; 2010; 89(2):199-204. PubMed ID: 19900078
[TBL] [Abstract][Full Text] [Related]
13. Endocrine factors associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome: do androgens play a role?
Kauffman RP; Baker TE; Baker V; Kauffman MM; Castracane VD
Gynecol Endocrinol; 2010 Jan; 26(1):39-46. PubMed ID: 20001571
[TBL] [Abstract][Full Text] [Related]
14. Role of ovary and adrenal glands in hyperandrogenemia in patients with polycystic ovary syndrome.
Kamel N; Tonyukuk V; Emral R; Corapçioğlu D; Baştemir M; Güllü S
Exp Clin Endocrinol Diabetes; 2005 Feb; 113(2):115-21. PubMed ID: 15772904
[TBL] [Abstract][Full Text] [Related]
15. Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome.
Van Nieuwerburgh F; Stoop D; Cabri P; Dhont M; Deforce D; De Sutter P
Gynecol Endocrinol; 2008 Dec; 24(12):669-73. PubMed ID: 19172534
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome.
Livadas S; Pappas C; Karachalios A; Marinakis E; Tolia N; Drakou M; Kaldrymides P; Panidis D; Diamanti-Kandarakis E
Endocrine; 2014 Nov; 47(2):631-8. PubMed ID: 24752393
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population.
Pehlivanov B; Orbetzova M
Gynecol Endocrinol; 2007 Oct; 23(10):604-9. PubMed ID: 17852429
[TBL] [Abstract][Full Text] [Related]
18. Polycystic ovary syndrome.
Chihal HJ; Baudier MM
Am Fam Physician; 1985 Apr; 31(4):159-65. PubMed ID: 3157301
[TBL] [Abstract][Full Text] [Related]
19. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women.
Liou TH; Yang JH; Hsieh CH; Lee CY; Hsu CS; Hsu MI
Fertil Steril; 2009 Dec; 92(6):1960-5. PubMed ID: 18980763
[TBL] [Abstract][Full Text] [Related]
20. Association of Perforin and Granzyme-B Levels with Hyperandrogenism in Polycystic Ovary Syndrome: A Case-Control Study.
Zarei E; Mohajery H; Aliakbari F; Zadeh FM; Veghari G; Mansourian A
Pak J Biol Sci; 2019 Jan; 22(8):393-399. PubMed ID: 31930827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]